, Tracking Stock Market Picks
Enter Symbol:
Medtronic, Inc. (MDT) [hlAlert]

Hold MDT
up 6.27 %

Medtronic, Inc. (MDT) downgraded to Hold by Argus

Posted on: Wednesday,  Nov 20, 2013  8:25 AM ET by Argus

Argus rated Hold Medtronic, Inc. (NYSE: MDT) on 11/20/2013. Previously Argus rated Buy Medtronic, Inc. (NYSE: MDT) on 07/17/2013., when
the stock price was $54.38. Since then, Medtronic, Inc. has gained 6.27% as of 11/20/2013's recent price of $57.79.
If you would have followed the previous Argus's recommendation on MDT, you would have gained 6.27% of your investment in 126 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2013 8:25 AM Hold
as of 12/13/2013
1 Week   
1 Month down  -0.68 %
3 Months up  7.85 %
1 YTD up  40.88 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/17/2013 8:25 AM Buy
54.38 63.00
2/22/2013 8:25 AM Buy
45.00 54.00
8/17/2012 9:25 AM Buy
40.75 48.00
3/9/2012 8:25 AM Sell
9/1/2011 8:25 AM Hold
5/31/2011 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy